Dec 08, 2010
This research undertaking is the result of a detailed analysis of the late stage R&D pipeline of the 50 top companies in pharmaceuticals, the companies that produce the lion's share of revenues. While the report looks at the entire pipeline to 2015
Dec 08, 2010
In seven best-selling editions, Shara Rosen has provided a total view of every aspect of the market for in vitro diagnostic (IVD) testing in one complete volume
Dec 07, 2010
Vaccines have been one of the faster growing areas of the pharmaceutical industry, and during a troubling series of years, they have been the superstars of many companies' portfolios.
Dec 07, 2010
The development of prosthetic materials ushered in the current era of hernia surgery, allowing a tension-free repair to be performed even for the largest defects and the most difficult procedures.
Dec 07, 2010
Kalorama has been researching and examining the development of cancer vaccines for seven years. In April 2010
Dec 07, 2010
Latin America is one of the areas that IVD companies are looking to for additional opportunities for IVD products. Among Latin American countries
Dec 07, 2010
IVD companies are looking to for additional opportunities for IVD products. Among northern hemisphere countries, Mexico's population
Dec 07, 2010
The market for respiratory disposables and reusable accessories is currently witnessing dynamic changes, thus making it one of the most important device sectors
Dec 06, 2010
This Kalorama Information report , The World Market for Diabetes Treatments, provides market estimates and forecasts for the world market for diabetes treatments
Dec 06, 2010
This report is the second edition of the report “Physician Office Testing, Worldwide: Status Quo and Future Trends” that was first published in 2007. The report concentrates on how the market for POL testing has evolved from 2007 to 2010.